Name of bioresource/bank
DNA and cell bank of the Cricm
Name of Principal Investigator
Address of institution where award is held
Contact email (e.g. manager or coordinator)
*French public research fundings from:
-research organisations (Inserm, CNRS) and universities (UPMC PARIS 6)
– research programs (ANR, national research agency; PHRC: hospital programs for clinical research)
*European research initiatives (FP6, FP7, e-rare Eranet)
*Few private funds from lab companies
Q1 What conditions does your resource cover?
Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
Above 5000 donors
Q2b What cell lines does your resource hold?
Above 1000 distinct cell lines
Q2c What tissue (including post-mortem tissue) does your resource hold?
Q3 Are human tissues/samples/DNA from
Living donors: blood derivatives
Living donors: DNA
Living donors: other, please specify below
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records
In a specific study-associated dataset
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed)
Secondary samples: plasma
Secondary samples: DNA
Secondary samples: cell lines derived from primary samples
Secondary samples: other types of cell lines
Secondary samples: other (please specify)
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
Q8 What is the status of your tissue/sample/DNA collection?
Q9 What are the rules and procedures for access?
Apply to PI or co-ordinator at resource
Access through collaboration with PI only
Access to industry
Access for pilot studies permitted
Applicant needs to provide separate external ethics approval